Loading clinical trials...

A Bioequivalence Study of Hetrombopag in Healthy Subjects | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT05088655

A Bioequivalence Study of Hetrombopag in Healthy Subjects

This study consists of two parts. Part 1 is a pilot BE study, and Part 2 is a pivotal study to demonstrate the bioequivalence of test and reference formulation, both of which adopt a single-center, ra...

Lead sponsor: Jiangsu HengRui Medicine Co., Ltd.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

NCT07010237 · Sever Aplastic Anaemia, Elderly (People Aged 65 or More), and more

COMPLETEDPhase 1

A Trial of Hetrombopag in Healthy Subjects

NCT05088174 · Sever Aplastic Anaemia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 4, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment58

Start dateJun 2021

Last updatedDec 4, 2023

Condition

Sever Aplastic Anaemia

Locations shown

The People's Hospital Of Liaoning Province

Shenyang, Liaoning

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 4, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions